Late Onset Neuromyelitis Optica Spectrum Disorder with Anti‐aquaporin 4 and Anti‐myelin Oligodendrocyte Glycoprotein Antibodies

Liang Wang,Hongmei Tan,Wenjuan Huang,Xuechun Chang,Jingzi ZhangBao,Lei Zhou,Chuanzhen Lu,Min Wang,Jiahong Lu,Chongbo Zhao,Chao Quan
DOI: https://doi.org/10.1111/ene.15239
2022-01-01
European Journal of Neurology
Abstract:This study aimed to evaluate the clinical characteristics and prognosis of late onset (≥50 years) neuromyelitis optica spectrum disorder (LO‐NMOSD), and compare them with those of early onset (<50 years) NMOSD (EO‐NMOSD) and NMOSD with various antibody serostatuses.
What problem does this paper attempt to address?